Business
New Partner In Central China
New Partner In Central China.
About this update from Tian'an Pharmaceutical Co., Ltd.
[{"type":"text","content":"SDG Global Group Inc (the “Company” or “SDG”) has signed a Memorandum of Understanding (MOU) with Henan Europe-China Cultural Development Limited (“HECCD”) for a wide ranging partnership to work together to identify investment, consulting and partnership opportunities for SDG, its associates and portfolio companies.HECCD is a leading business advisory firm, based in Zhengzhou, Henan Province, with its’ operations and network spanning central China. It focuses on business development and advice, especially for cross border and Belt And Road Initiative (OBOR) transactions, working closely with Henan Government and local companies. The core focus is in education, healthcare, cultural development, agriculture and food, and advanced technology.Ms Baohong Wang, CEO of HECCD, commented: “We are very happy that SDG is expanding its’ cooperation with us and looking to do more projects in Henan. We look forward to working together in Central and Western China, areas where there is a strong need for international technology and service providers and partners, especially in healthcare, education and cultural development.\"Simon Littlewood, President of SDG, commented: \"We are delighted to be working with Baohong and her team. HECCD has strong access to local businesses and governments, as well as to the European Union, which is an area of increased interest for Chinese businesses and investors as a result of the US-China trade tensions, and the OBOR. SDG has already begun working with HECCD on a senior care home management project, and a university project.Henan is an important region in China. In 2016 it was designated as a Pilot Free Trade Zone, with a range of incentives to attract foreign investment and technology. It is also a key logistics hub for the OBOR project, linking China with Europe and Central Asia.”For a full copy of the announcement, see the attachmentThis news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. All statements o...